“`html

Novel therapy for Alcohol Use Disorder Enters Clinical trial Phase

A groundbreaking clinical trial is underway, offering new hope for individuals struggling with alcohol use disorder (AUD).The first participant has received a dose of cmnd-100, an investigational oral medication developed by Clearmind Medicine Inc., marking a critically important milestone in the search for effective AUD treatments. This initial dosing signifies the start of a Phase I/IIA study designed to assess the drug’s safety, tolerability, and potential efficacy.

Understanding Alcohol use Disorder: A Global Health Crisis

The harmful use of alcohol is a major public health concern worldwide, contributing to approximately 2.6 million deaths annually [[1]]. Alcohol is implicated in over 230 different diseases [[1]] and extends its negative impact beyond the drinker, affecting the well-being of families and communities. In 2019, global alcohol consumption reached an average of 5.5 liters of pure alcohol per person aged 15 years and older [[1]].

Did you Know?

Alcohol suppresses the immune system, increasing susceptibility to infectious diseases like tuberculosis